FDA inspection
Merck Sharp & Dohme LLC: FDA inspection ending Dec 12, 2024
FDA inspection 1252348 · No Action Indicated (NAI) · West Point, PA
Key facts
| Inspection ID | 1252348 |
|---|---|
| Firm | Merck Sharp & Dohme LLC |
| FEI number | 2510592 |
| Address | 770 Sumneytown Pike |
| City | West Point |
| State | PA |
| ZIP | 19486 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Dec 12, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data